Ignite Creation Date:
2025-12-24 @ 1:48 PM
Ignite Modification Date:
2026-01-27 @ 8:16 AM
Study NCT ID:
NCT01213095
Status:
COMPLETED
Last Update Posted:
2016-04-11
First Post:
2010-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)
Sponsor:
Organization: